Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 309, Issue 3, pp 235–239 | Cite as

Clonidine mydriasis in the cat

Further evidence for a CNS postsynaptic action
  • Michael C. Koss
Article

Summary

Both clonidine (1–100 μg/kg, i.v.) and d-amphetamine (500 μg, i.c.v.) produced mydriasis associated with depression of tonic ciliary nerve activity in the anaesthetized cat. Clonidine administration in preparations depleted of noradrenaline, dopamine and serotonin by pretreatment with reserpine (5 mg/kg, i.p.) and α-methyl-p-tyrosine (2×300 mg/kg, i.p.) resulted in a quantitatively similar mydriasis and inhibition of nerve activity. Thus it is concluded that both drugs cause pupillary dilation by inhibition of parasympathetic tone to the iris and that clonidine's action on this particular system is probably postsynaptic.

In contrast, amine depletion totally prevented amphetamine-induced mydriasis and parasympathetic nerve depression, supporting the contention that centrally administered amphetamine acts in this system by means of releasing endogenous stores of monoamines. Pretreatment with yohimbine (0.5 mg/kg, i.v.) totally blocked the effects of i.c.v. amphetamine as it does with clonidine.

These studies suggest that the pupillary dilation by i.v. clonidine and i.c.v. amphetamine is primarily the result of central inhibition of parasympathetic tone to the iris. It would appear that clonidine produces this effect by acting on postsynaptic mechanisms and that amphetamine acts indirectly through release of an endogenous inhibitory neurotransmitter. The observation that the effects of both of these compounds are blocked by yohimbine supports the suggestion that a central adrenergic inhibitory mechanism is involved.

Key words

Clonidine d-amphetamine Yohimbine Ciliary nerve activity Monoamine depletion 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andén, N. E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9, 513–523 (1970)Google Scholar
  2. Bolme, P., Corrodi, H., Fuxe, K., Hökfelt, T., Lidbrink, P., Goldstein, M.: Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine. Eur. J. Pharmacol. 28, 89–94 (1974)Google Scholar
  3. Briant, R. H., Reid, J. L., Dollery, C. T.: Interaction between clonidine and desipramine in man. Br. Med. J. 1, 522–523 (1973)Google Scholar
  4. Dollery, C. T., Reid, J. L.: Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit. Br. J. Pharmacol. 47, 206–216 (1973)Google Scholar
  5. Haeusler, G.: Activation of the central pathway of the baroreceptor reflex; a possible mechanism of the hypotensive action of clonidine. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 231–246 (1973)Google Scholar
  6. Haeusler, G.: Clonidine-induced inhibition of sympathetic nerve activity: No indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn-Schmiedeberg's Arch. Pharmacol. 286, 97–111 (1974)Google Scholar
  7. Hoefke, W., Warnke-Sachs, E.: Influence of desmethylimipramine on the hypotensive effect of clonidine. Arzneim.-Forsch. (Drug Res.) 24, 1046–1047 (1974)Google Scholar
  8. Hoyer, I., van Zwieten, P. A.: The central hypotensive action of amphetamine, ephedrine, phentermine, chlorphentermine and fenfluramine. J. Pharm. Pharmacol. 24, 452–458 (1972)Google Scholar
  9. Klupp, H., Knappen, F., Otsuka, Y., Streller, I., Teichmann, H.: Effects of clonidine on central sympathetic tone. Eur. J. Pharmacol. 10, 225–229 (1970)Google Scholar
  10. Kobinger, W.: Central α-adrenergic systems as tergets for hypotensive drugs. Rev. Physiol. Biochem. Pharmacol. 81, 39–100 (1978)Google Scholar
  11. Kobinger, W., Pichler, L.: The central modulatory effect of clonidine on the cardiodepressor reflex after suppression of synthesis and storage of noradrenaline. Eur. J. Pharmacol. 30, 56–62 (1975)Google Scholar
  12. Kobinger, W., Pichler, L.: Differentiation of drugs acting centrally upon the cardiovascular system by means of sympathetic and vagal responses. Clin. Exp. Hyperten. 1, 229–249 (1978)Google Scholar
  13. Kobinger, W., Walland, A.: Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline-HCl. Eur. J. Pharmacol. 2, 155–162 (1967)Google Scholar
  14. Koss, M. C.: Effect of clonidine and chlorpromazine on centrally evoked electrodermal responses and their interaction with yohimbine. Eur. J. Pharmacol. 41, 221–224 (1977)Google Scholar
  15. Koss, M. C.: Topical clonidine produces mydriasis by a central nervous system action. Eur. J. Pharmacol. 55, 305–310 (1979)Google Scholar
  16. Koss, M. C., Bernthal, P. J.: Potentiation of two sympathetic reflexes by yohimbine hydrochloride. Neuropharmacology 18, 295–300 (1979)Google Scholar
  17. Koss, M. C., Christensen, H. D.: Evidence for a central postsynaptic action of clonidine. Naunyn-Schmiedeberg's Arch. Pharmacol. 307, 45–50 (1979b)Google Scholar
  18. Koss, M. C., Davison, M. A.: The electrodermal response as a model for central sympathetic reactivity: the action of clonidine. Eur. J. Pharmacol. 37, 71–78 (1976)Google Scholar
  19. Koss, M. C., San, L. C.: Analysis of clonidine-induced mydriasis. Invest. Ophthalmol. Visual Sci. 15, 566–570 (1976)Google Scholar
  20. Marley, E.: the significance of mydriasis produced by amphetamine sulphate. Psychopharmacologia (Berl.) 2, 243–257 (1961)Google Scholar
  21. Rand, M. J., Rush, M., Wilson, J.: Some observation on the inhibition of salivation by ST 155 [2-(2,6-dichlorophenylamine)-2-imidazoline hydrochloride, Catapres, Catapresan]. Eur. J. Pharmacol. 5, 168–172 (1969)Google Scholar
  22. Reid, J. L., Briant, R. H., Dollery, C. T.: Desmethylimipramine and the hypotensive action of clonidine in the rabbit. Life Sci. 12, 459–467 (1973)Google Scholar
  23. Reynoldson, J. A., Head, G. A., Korner, P. I.: Effect of 6-hydroxydopamine on blood pressure and heart rate responses to intracisternal clonidine in conscious rabbits. Eur. J. Pharmacol. 55, 257–262 (1979)Google Scholar
  24. Sattler, R. W., van Zwieten, P. A.: Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery. Eur. J. Pharmacol. 2, 9–13 (1967)Google Scholar
  25. Schmitt, H., Schmitt, H.: Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan) and α-adrenergic blocking drugs. Eur. J. Pharmacol. 9, 7–13 (1970)Google Scholar
  26. Schmitt, H., Schmitt, H., Boissier, J. R., Guidicelli, J. F., Fichelle, J.: Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155). II. Central sympathetic structures. Eur. J. Pharmacol. 2, 340–346 (1968)Google Scholar
  27. Schmitt, H., Schmitt, H., Fénard, S.: Action of α-adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine. Arzneim.-Forsch. (Drug Res.) 23, 40–45 (1973)Google Scholar
  28. Sharpe, L. G., Pickworth, W. B., Martin, W. R.: Actions of amphetamine and antagonists on pupil diameter in the chronic sympathectomized dog. Psychopharmacology 53, 115–120 (1977)Google Scholar
  29. van Spanning, H. W., van Zwieten, P. A.: The interference of tricyclic antidepressants with the central hypotensive effect of clonidine. Eur. J. Pharmacol. 24, 402–404 (1973)Google Scholar
  30. Warnke, E., Hoefke, W.: Influence of central pretreatment with 6-hydroxydopamine on the hypotensive effect of clonidine. Arzneim.-Forsch. (Drug Res.) 27, 2311–2313 (1977)Google Scholar
  31. Yonkman, F. F., Stilwell, D., Jeremias, R.: The adrenolytic and sympatholytic actions of yohimbine and ethyl yohimbine. J. Pharmacol. Exp. Ther. 81, 111–115 (1944)Google Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • Michael C. Koss
    • 1
  1. 1.Departments of Pharmacology and of Ophthalmology and McGee Eye InstituteUniversity of Oklahoma, Health Sciences CenterOklahoma CityUSA

Personalised recommendations